Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | RECQL | P46063 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | GMNN | O75496 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | FYN | P06241 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | CA3 | P07451 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | MMP9 | P14780 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL27738150 | 0.98 | ALDH1A1 (0.40) | ALDH1A1HPGDHSD17B10BCL2L1SMN1; SMN2 | |
| Biphenyl SCHEMBL27502002 | 0.93 | HPGD (0.50) | ALDH1A1HPGDHSD17B10BCL2L1SMN1; SMN2 | |
| Biphenyl SCHEMBL27708316 | 0.86 | HPGD (0.47) | ALDH1A1HPGDHSD17B10BCL2L1SMN1; SMN2 | |
| SCHEMBL30626777 | 0.84 | — | — | |
| SCHEMBL28006187 | 0.84 | — | — | |
| SCHEMBL10495969 | 0.82 | MAOA (0.39) | ALDH1A1HPGDHSD17B10SMN1; SMN2MAPT | |
| SCHEMBL28856005 | 0.82 | HSD17B10 (0.40) | ALDH1A1HPGDHSD17B10BCL2L1SMN1; SMN2 | |
| SCHEMBL27365125 | 0.80 | ALDH1A1 (0.39) | ALDH1A1HPGDHSD17B10BCL2L1SMN1; SMN2 | |
| SCHEMBL29938717 | 0.80 | ALDH1A1 (0.39) | ALDH1A1HPGDHSD17B10BCL2L1SMN1; SMN2 | |
| SCHEMBL21044936 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115322278-B | Sulfonated nitrostyrene resin and preparation method and application thereof | 杭摩科技新材料(阜阳)有限公司 | 2024-06-07 | — | — | CN | claimed |
| CN-115322278-B | Sulfonated nitrostyrene resin and preparation method and application thereof | 杭摩科技新材料(阜阳)有限公司 | 2024-06-07 | — | — | CN | disclosed |
| CN-117417518-A | Hyperbranched active ester polymer and preparation method and application thereof | 北京化工大学 | 2024-01-19 | — | — | CN | disclosed |
| CN-116410223-A | Tetraarylethoxy side chain single metallocene compound, catalyst system containing same and polyolefin synthesis method using same | 中国石油天然气股份有限公司 | 2023-07-11 | — | — | CN | disclosed |
| WO-2023123884-A1 | TETRAARYL ETHOXY SIDE-CHAIN MONO-METALLOCENE COMPOUND, CATALYST SYSTEM COMPRISING SAME, AND POLYOLEFIN SYNTHESIS METHOD USING SAME | 中国石油天然气股份有限公司 | 2023-07-06 | — | — | WO | disclosed |
| US-8252561-B2 | Production of biofuel using molluscan pseudofeces derived from algal cells | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2012-08-28 | — | — | US | disclosed |
| US-20110105554-A1 | MEANS FOR TREATING MYOSIN-RELATED DISEASES | KINARIS BIOMEDICALS GMBH (DE) | 2011-05-05 | — | — | US | disclosed |
| CN-100506768-C | 2,4-di-(1-phenylisopropyl) phenol preparation method | CHINA PETROLEUM & CHEMICAL (CN) | 2009-07-01 | — | — | CN | disclosed |
| CN-100491315-C | Process for preparing 2,4-dicumyl phenol | CHINA PETROLEUM & CHEMICAL (CN) | 2009-05-27 | — | — | CN | disclosed |
| CN-1962591-A | 2,4-di-(1-phenylisopropyl) phenol preparation method | CHINA PETROLEUM & CHEMICAL (CN) | 2007-05-16 | — | — | CN | disclosed |
| CN-1884245-A | Process for preparing 2,4-dicumyl phenol | CHINA PETROLEUM & CHEMICAL (CN) | 2006-12-27 | — | — | CN | disclosed |
| CN-1034547-A | CATALYST FOR POLYMERIZATION OF ALPHA-OLEFINE AND POLYMERIZATION PROCESS | MITSUI PETROCHEMICAL IND (JP) | 1989-08-09 | — | — | CN | disclosed |
| US-4484010-A | POLYMER ANTIOXIDANT | THE B. F. GOODRICH COMPANY (US) | 1984-11-20 | — | — | US | disclosed |
| EP-0113666-A1 | Hydroxybenzylcyclopentadienes and derivatives thereof | The B.F. GOODRICH Company (US) | 1984-07-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110105554-A1 | MEANS FOR TREATING MYOSIN-RELATED DISEASES | MYH14, MYH2, MYLK2 | ALDH1A1 4152/4885HPGD 2787/4885HSD17B10 3843/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.